FTY720 has been shown to increase the cisplatin sensitivity of lung cancer cell through the activation of PP2A49 and enhance cell death in combination with cisplatin by inhibiting the Akt and epidermal growth factor (EGF) pathways in melanoma cells50. The gene discussed is AKT1; the disease is melanoma.